Back to Results
First PageMeta Content
Entecavir / Purines / Interferon / Interferon type I / Nitazoxanide / Cytokines / Antivirals / Bristol-Myers Squibb


New HBV Treatment Options on the Horizon Harry L.A. Janssen Director of Liver Clinic Toronto Western & General Hospitals University of Toronto, Canada
Add to Reading List

Document Date: 2014-11-06 11:19:20

Open Document

File Size: 976,38 KB

Share Result on Facebook

Company

Merck / /

Continent

Asia / /

Facility

General Hospitals University of Toronto / Canada Erasmus University Medical Center / Liver Clinic / /

IndustryTerm

healthcare / HBV Treatment / /

MedicalCondition

disease / HBV / /

Organization

Canada Erasmus University Medical Center Rotterdam / National Institute of Health / University of Toronto / /

Position

Horizon Harry L.A. Janssen Director / Director of Liver Clinic Toronto Western & General / /

Product

Unlicensed Medication / Licensed Medication / /

SocialTag